Moreover, germline polymorphisms of IL-8 and vascular endothelial growth factor (VEGF), two genes involved in tumor angiogenesis, are associated with increased risk of recurrence in stage III CRC patients treated with adjuvant chemotherapy (65). The gene discussed is CXCL8; the disease is colorectal carcinoma.